A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
for Colon Adenocarcinoma
Drug: Calderasib
26 locations incl. Los Angeles
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06997497·Phase 3·Recruiting